Evidence map›Paper›PMID 35991838›Full record

ArticlePathology oncology research : POR2022

Case Report: Clinicopathological and Genetic Features of IDH-Mutant Brainstem Glioma in Adults: Report of Five Cases.

Jiangfen Zhou, Mingyao Lai, Yang Ni, Shaoqun Li, Junjie Zhen, Furong Du, Xing Zhang, Chao Song, Linbo Cai

Open access · goldAbstract readCase Reports
In one paragraph

Article in Pathology oncology research : POR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jiangfen ZhouDepartment of Neuro-Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, China.
Mingyao LaiDepartment of Neuro-Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, China.
Yang NiState Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, China.
Shaoqun LiDepartment of Neuro-Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, China.
Junjie ZhenDepartment of Neuro-Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, China.
Furong DuState Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, China.
Xing ZhangState Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, China.
Chao SongState Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing, China.
Linbo CaiDepartment of Neuro-Oncology, Guangdong Sanjiu Brain Hospital, Guangzhou, China.
Guangdong 999 Brain Hospital · CNSimcere Pharmaceutical (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adult brainstem gliomas are rare central nervous system tumors that represent a heterogeneous group of tumors. Somatic

Indexed as

Brain NeoplasmsGliomaAdultBrain StemHumansIsocitrate DehydrogenasePrognosisIsocitrate Dehydrogenasebrainstem gliomaIDH1 mutationmolecular featuresprognosistemozolomide

Identifiers

PMID35991838
PMCPMC9385964
OpenAlexW4289731336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.